Home/Filings/4/0001628280-24-011773
4//SEC Filing

Desai Veeral 4

Accession 0001628280-24-011773

CIK 0001831097other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:42 PM ET

Size

7.2 KB

Accession

0001628280-24-011773

Insider Transaction Report

Form 4
Period: 2024-03-14
Desai Veeral
Chief Strategy & Dev. Officer
Transactions
  • Tax Payment

    Common Stock

    2024-03-14$5.23/sh4,900$25,627306,641 total
  • Purchase

    Common Stock

    2024-03-14+11,956311,541 total
Footnotes (5)
  • [F1]This award was granted on April 14, 2021 and all remaining performance-based restricted stock units (PSUs) subject to the award vested on March 14, 2024.
  • [F2]The number of PSUs that vested was determined based on agilon health's predetermined Revenue and Adjusted EBITDA goals over a three-year period from January 1, 2021 through December 31, 2023. Total attainment achieved was 100%.
  • [F3]Each PSU represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of PSUs in shares of common stock on their scheduled vesting date.
  • [F4]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PSUs and does not represent a sale.
  • [F5]Includes restricted stock units.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855973

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:42 PM ET
Size
7.2 KB